Autoimmune Hemolytic Anemia in a Patient with Primary Ovarian Non-Hodgkin's Lymphoma.
10.3346/jkms.2004.19.2.294
- Author:
Chang Kil JUNG
1
;
Jong Seung PARK
;
Eun Ju LEE
;
Sung Hyun KIM
;
Hyuk Chan KWON
;
Jae Seok KIM
;
Mee Sook ROH
;
Seoung Kook YOON
;
Kyeong Hee KIM
;
Jin Yeong HAN
;
Hyo Jin KIM
Author Information
1. Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea. kimhj@mail.donga.ac.kr
- Publication Type:Case Report
- Keywords:
Ovarian Neoplasms;
Lymphoma, Non-Hodgkin;
Hemolytic Anemia, Autoimmune
- MeSH:
Adult;
Anemia, Hemolytic/*immunology;
Antineoplastic Agents, Hormonal/therapeutic use;
Autoimmune Diseases/immunology;
Combined Modality Therapy;
Female;
Human;
Lymphoma, Non-Hodgkin/*complications/drug therapy/pathology/surgery;
Ovarian Neoplasms/*complications/drug therapy/pathology/surgery;
Prednisolone/therapeutic use
- From:Journal of Korean Medical Science
2004;19(2):294-296
- CountryRepublic of Korea
- Language:English
-
Abstract:
The primary ovarian lymphoma is a rare disease with poor prognosis. The incidence of autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma is estimated at 3%. However, a substantial portion of the previously reported cases of ovarian lymphoma actually represented ovarian involvement by more diffuse lymphomatous process. If stringent criteria are used for case selection, true primary ovarian lymphoma usually carries a favorable prognosis. We present a primary malignant lymphoma of ovary accompanied by autoimmune hemolytic anemia in a 29-yr-old patient. After ablative surgery, the hemoglobin level and the reticulocyte count were normalized. One year following surgery and chemotherapy, the patient is alive and disease free.
